News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Results> Everest Medicines (01952.HK) Narrows Annual Loss to RMB298 Million, No Dividend
Everest Medicines (01952.HK) announced its annual results for the year ended last December, with a revenue of RMB1.707 billion, representing a year-on-year increase of 141.5%. The ...
Reset
Send
The window will close in 5 seconds
<Results> Everest Medicines (01952.HK) Narrows Annual Loss to RMB298 Million, No Dividend
Close
Recommend
4
Positive
1
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

Everest Medicines (01952.HK)  -0.820 (-2.759%)    Short selling $28.97M; Ratio 20.784%   announced its annual results for the year ended last December, with a revenue of RMB1.707 billion, representing a year-on-year increase of 141.5%. The loss narrowed to RMB298 million, compared to a loss of RMB1.041 billion in the same period last year; the loss per share was RMB0.89. No dividend will be distributed. (ca/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-03 12:25.)

Dividend History
Announce DateEventParticular
2025/08/29InterimNo Dividend
2025/03/26FinalNo Dividend
2024/08/28InterimNo Dividend
2024/03/28FinalNo Dividend

Related News M Stanley Ratings and TPs on China Biotech Stocks
Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.